- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
According to our latest study, the global Non-Animal Softgel Capsules market size was valued at USD 569 million in 2022 and is forecast to a readjusted size of USD 907.2 million by 2029 with a CAGR of 6.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.
Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.
Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.
This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
This report is a detailed and comprehensive analysis for global Non-Animal Softgel Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Animal Softgel Capsules market size and forecasts, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2018-2029
Global Non-Animal Softgel Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2018-2029
Global Non-Animal Softgel Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2018-2029
Global Non-Animal Softgel Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (M Capsules), and ASP (US$/Capsule), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Animal Softgel Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Animal Softgel Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Procaps Laboratorios, EuroCaps, Best Formulations and Aenova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-Animal Softgel Capsules market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Market segment by Application
Health Supplements
Pharmaceutical
Others
Major players covered
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Animal Softgel Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Animal Softgel Capsules, with price, sales, revenue and global market share of Non-Animal Softgel Capsules from 2018 to 2023.
Chapter 3, the Non-Animal Softgel Capsules competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Animal Softgel Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-Animal Softgel Capsules market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Animal Softgel Capsules.
Chapter 14 and 15, to describe Non-Animal Softgel Capsules sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Non-Animal Softgel Capsules
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-Animal Softgel Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Plant Polysaccharides Softgel Capsules
1.3.3 Starch Softgel Capsules
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-Animal Softgel Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Supplements
1.4.3 Pharmaceutical
1.4.4 Others
1.5 Global Non-Animal Softgel Capsules Market Size & Forecast
1.5.1 Global Non-Animal Softgel Capsules Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-Animal Softgel Capsules Sales Quantity (2018-2029)
1.5.3 Global Non-Animal Softgel Capsules Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Non-Animal Softgel Capsules Product and Services
2.1.4 Catalent Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Catalent Recent Developments/Updates
2.2 Procaps Laboratorios
2.2.1 Procaps Laboratorios Details
2.2.2 Procaps Laboratorios Major Business
2.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Product and Services
2.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Procaps Laboratorios Recent Developments/Updates
2.3 EuroCaps
2.3.1 EuroCaps Details
2.3.2 EuroCaps Major Business
2.3.3 EuroCaps Non-Animal Softgel Capsules Product and Services
2.3.4 EuroCaps Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 EuroCaps Recent Developments/Updates
2.4 Best Formulations
2.4.1 Best Formulations Details
2.4.2 Best Formulations Major Business
2.4.3 Best Formulations Non-Animal Softgel Capsules Product and Services
2.4.4 Best Formulations Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Best Formulations Recent Developments/Updates
2.5 Aenova
2.5.1 Aenova Details
2.5.2 Aenova Major Business
2.5.3 Aenova Non-Animal Softgel Capsules Product and Services
2.5.4 Aenova Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aenova Recent Developments/Updates
2.6 Captek
2.6.1 Captek Details
2.6.2 Captek Major Business
2.6.3 Captek Non-Animal Softgel Capsules Product and Services
2.6.4 Captek Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Captek Recent Developments/Updates
2.7 Sirio
2.7.1 Sirio Details
2.7.2 Sirio Major Business
2.7.3 Sirio Non-Animal Softgel Capsules Product and Services
2.7.4 Sirio Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sirio Recent Developments/Updates
2.8 Bahrain Pharma
2.8.1 Bahrain Pharma Details
2.8.2 Bahrain Pharma Major Business
2.8.3 Bahrain Pharma Non-Animal Softgel Capsules Product and Services
2.8.4 Bahrain Pharma Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bahrain Pharma Recent Developments/Updates
2.9 Robinson Pharma
2.9.1 Robinson Pharma Details
2.9.2 Robinson Pharma Major Business
2.9.3 Robinson Pharma Non-Animal Softgel Capsules Product and Services
2.9.4 Robinson Pharma Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Robinson Pharma Recent Developments/Updates
2.10 Aland
2.10.1 Aland Details
2.10.2 Aland Major Business
2.10.3 Aland Non-Animal Softgel Capsules Product and Services
2.10.4 Aland Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aland Recent Developments/Updates
2.11 Fuji Capsule
2.11.1 Fuji Capsule Details
2.11.2 Fuji Capsule Major Business
2.11.3 Fuji Capsule Non-Animal Softgel Capsules Product and Services
2.11.4 Fuji Capsule Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Fuji Capsule Recent Developments/Updates
2.12 Sunsho Pharmaceutical
2.12.1 Sunsho Pharmaceutical Details
2.12.2 Sunsho Pharmaceutical Major Business
2.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product and Services
2.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sunsho Pharmaceutical Recent Developments/Updates
2.13 Erkang
2.13.1 Erkang Details
2.13.2 Erkang Major Business
2.13.3 Erkang Non-Animal Softgel Capsules Product and Services
2.13.4 Erkang Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Erkang Recent Developments/Updates
3 Competitive Environment: Non-Animal Softgel Capsules by Manufacturer
3.1 Global Non-Animal Softgel Capsules Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-Animal Softgel Capsules Revenue by Manufacturer (2018-2023)
3.3 Global Non-Animal Softgel Capsules Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-Animal Softgel Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-Animal Softgel Capsules Manufacturer Market Share in 2022
3.4.2 Top 6 Non-Animal Softgel Capsules Manufacturer Market Share in 2022
3.5 Non-Animal Softgel Capsules Market: Overall Company Footprint Analysis
3.5.1 Non-Animal Softgel Capsules Market: Region Footprint
3.5.2 Non-Animal Softgel Capsules Market: Company Product Type Footprint
3.5.3 Non-Animal Softgel Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-Animal Softgel Capsules Market Size by Region
4.1.1 Global Non-Animal Softgel Capsules Sales Quantity by Region (2018-2029)
4.1.2 Global Non-Animal Softgel Capsules Consumption Value by Region (2018-2029)
4.1.3 Global Non-Animal Softgel Capsules Average Price by Region (2018-2029)
4.2 North America Non-Animal Softgel Capsules Consumption Value (2018-2029)
4.3 Europe Non-Animal Softgel Capsules Consumption Value (2018-2029)
4.4 Asia-Pacific Non-Animal Softgel Capsules Consumption Value (2018-2029)
4.5 South America Non-Animal Softgel Capsules Consumption Value (2018-2029)
4.6 Middle East and Africa Non-Animal Softgel Capsules Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-Animal Softgel Capsules Sales Quantity by Type (2018-2029)
5.2 Global Non-Animal Softgel Capsules Consumption Value by Type (2018-2029)
5.3 Global Non-Animal Softgel Capsules Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-Animal Softgel Capsules Sales Quantity by Application (2018-2029)
6.2 Global Non-Animal Softgel Capsules Consumption Value by Application (2018-2029)
6.3 Global Non-Animal Softgel Capsules Average Price by Application (2018-2029)
7 North America
7.1 North America Non-Animal Softgel Capsules Sales Quantity by Type (2018-2029)
7.2 North America Non-Animal Softgel Capsules Sales Quantity by Application (2018-2029)
7.3 North America Non-Animal Softgel Capsules Market Size by Country
7.3.1 North America Non-Animal Softgel Capsules Sales Quantity by Country (2018-2029)
7.3.2 North America Non-Animal Softgel Capsules Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-Animal Softgel Capsules Sales Quantity by Type (2018-2029)
8.2 Europe Non-Animal Softgel Capsules Sales Quantity by Application (2018-2029)
8.3 Europe Non-Animal Softgel Capsules Market Size by Country
8.3.1 Europe Non-Animal Softgel Capsules Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-Animal Softgel Capsules Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-Animal Softgel Capsules Market Size by Region
9.3.1 Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-Animal Softgel Capsules Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-Animal Softgel Capsules Sales Quantity by Type (2018-2029)
10.2 South America Non-Animal Softgel Capsules Sales Quantity by Application (2018-2029)
10.3 South America Non-Animal Softgel Capsules Market Size by Country
10.3.1 South America Non-Animal Softgel Capsules Sales Quantity by Country (2018-2029)
10.3.2 South America Non-Animal Softgel Capsules Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-Animal Softgel Capsules Market Size by Country
11.3.1 Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-Animal Softgel Capsules Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-Animal Softgel Capsules Market Drivers
12.2 Non-Animal Softgel Capsules Market Restraints
12.3 Non-Animal Softgel Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-Animal Softgel Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-Animal Softgel Capsules
13.3 Non-Animal Softgel Capsules Production Process
13.4 Non-Animal Softgel Capsules Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-Animal Softgel Capsules Typical Distributors
14.3 Non-Animal Softgel Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Non-Animal Softgel Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Animal Softgel Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Catalent Basic Information, Manufacturing Base and Competitors
Table 4. Catalent Major Business
Table 5. Catalent Non-Animal Softgel Capsules Product and Services
Table 6. Catalent Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Catalent Recent Developments/Updates
Table 8. Procaps Laboratorios Basic Information, Manufacturing Base and Competitors
Table 9. Procaps Laboratorios Major Business
Table 10. Procaps Laboratorios Non-Animal Softgel Capsules Product and Services
Table 11. Procaps Laboratorios Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Procaps Laboratorios Recent Developments/Updates
Table 13. EuroCaps Basic Information, Manufacturing Base and Competitors
Table 14. EuroCaps Major Business
Table 15. EuroCaps Non-Animal Softgel Capsules Product and Services
Table 16. EuroCaps Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. EuroCaps Recent Developments/Updates
Table 18. Best Formulations Basic Information, Manufacturing Base and Competitors
Table 19. Best Formulations Major Business
Table 20. Best Formulations Non-Animal Softgel Capsules Product and Services
Table 21. Best Formulations Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Best Formulations Recent Developments/Updates
Table 23. Aenova Basic Information, Manufacturing Base and Competitors
Table 24. Aenova Major Business
Table 25. Aenova Non-Animal Softgel Capsules Product and Services
Table 26. Aenova Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Aenova Recent Developments/Updates
Table 28. Captek Basic Information, Manufacturing Base and Competitors
Table 29. Captek Major Business
Table 30. Captek Non-Animal Softgel Capsules Product and Services
Table 31. Captek Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Captek Recent Developments/Updates
Table 33. Sirio Basic Information, Manufacturing Base and Competitors
Table 34. Sirio Major Business
Table 35. Sirio Non-Animal Softgel Capsules Product and Services
Table 36. Sirio Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sirio Recent Developments/Updates
Table 38. Bahrain Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Bahrain Pharma Major Business
Table 40. Bahrain Pharma Non-Animal Softgel Capsules Product and Services
Table 41. Bahrain Pharma Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bahrain Pharma Recent Developments/Updates
Table 43. Robinson Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Robinson Pharma Major Business
Table 45. Robinson Pharma Non-Animal Softgel Capsules Product and Services
Table 46. Robinson Pharma Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Robinson Pharma Recent Developments/Updates
Table 48. Aland Basic Information, Manufacturing Base and Competitors
Table 49. Aland Major Business
Table 50. Aland Non-Animal Softgel Capsules Product and Services
Table 51. Aland Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Aland Recent Developments/Updates
Table 53. Fuji Capsule Basic Information, Manufacturing Base and Competitors
Table 54. Fuji Capsule Major Business
Table 55. Fuji Capsule Non-Animal Softgel Capsules Product and Services
Table 56. Fuji Capsule Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Fuji Capsule Recent Developments/Updates
Table 58. Sunsho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Sunsho Pharmaceutical Major Business
Table 60. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product and Services
Table 61. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sunsho Pharmaceutical Recent Developments/Updates
Table 63. Erkang Basic Information, Manufacturing Base and Competitors
Table 64. Erkang Major Business
Table 65. Erkang Non-Animal Softgel Capsules Product and Services
Table 66. Erkang Non-Animal Softgel Capsules Sales Quantity (M Capsules), Average Price (US$/Capsule), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Erkang Recent Developments/Updates
Table 68. Global Non-Animal Softgel Capsules Sales Quantity by Manufacturer (2018-2023) & (M Capsules)
Table 69. Global Non-Animal Softgel Capsules Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Non-Animal Softgel Capsules Average Price by Manufacturer (2018-2023) & (US$/Capsule)
Table 71. Market Position of Manufacturers in Non-Animal Softgel Capsules, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Non-Animal Softgel Capsules Production Site of Key Manufacturer
Table 73. Non-Animal Softgel Capsules Market: Company Product Type Footprint
Table 74. Non-Animal Softgel Capsules Market: Company Product Application Footprint
Table 75. Non-Animal Softgel Capsules New Market Entrants and Barriers to Market Entry
Table 76. Non-Animal Softgel Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Non-Animal Softgel Capsules Sales Quantity by Region (2018-2023) & (M Capsules)
Table 78. Global Non-Animal Softgel Capsules Sales Quantity by Region (2024-2029) & (M Capsules)
Table 79. Global Non-Animal Softgel Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Non-Animal Softgel Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Non-Animal Softgel Capsules Average Price by Region (2018-2023) & (US$/Capsule)
Table 82. Global Non-Animal Softgel Capsules Average Price by Region (2024-2029) & (US$/Capsule)
Table 83. Global Non-Animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Capsules)
Table 84. Global Non-Animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Capsules)
Table 85. Global Non-Animal Softgel Capsules Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Non-Animal Softgel Capsules Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Non-Animal Softgel Capsules Average Price by Type (2018-2023) & (US$/Capsule)
Table 88. Global Non-Animal Softgel Capsules Average Price by Type (2024-2029) & (US$/Capsule)
Table 89. Global Non-Animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Capsules)
Table 90. Global Non-Animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Capsules)
Table 91. Global Non-Animal Softgel Capsules Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Non-Animal Softgel Capsules Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Non-Animal Softgel Capsules Average Price by Application (2018-2023) & (US$/Capsule)
Table 94. Global Non-Animal Softgel Capsules Average Price by Application (2024-2029) & (US$/Capsule)
Table 95. North America Non-Animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Capsules)
Table 96. North America Non-Animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Capsules)
Table 97. North America Non-Animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Capsules)
Table 98. North America Non-Animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Capsules)
Table 99. North America Non-Animal Softgel Capsules Sales Quantity by Country (2018-2023) & (M Capsules)
Table 100. North America Non-Animal Softgel Capsules Sales Quantity by Country (2024-2029) & (M Capsules)
Table 101. North America Non-Animal Softgel Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Non-Animal Softgel Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Non-Animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Capsules)
Table 104. Europe Non-Animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Capsules)
Table 105. Europe Non-Animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Capsules)
Table 106. Europe Non-Animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Capsules)
Table 107. Europe Non-Animal Softgel Capsules Sales Quantity by Country (2018-2023) & (M Capsules)
Table 108. Europe Non-Animal Softgel Capsules Sales Quantity by Country (2024-2029) & (M Capsules)
Table 109. Europe Non-Animal Softgel Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Non-Animal Softgel Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Capsules)
Table 112. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Capsules)
Table 113. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Capsules)
Table 114. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Capsules)
Table 115. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Region (2018-2023) & (M Capsules)
Table 116. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Region (2024-2029) & (M Capsules)
Table 117. Asia-Pacific Non-Animal Softgel Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Non-Animal Softgel Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Non-Animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Capsules)
Table 120. South America Non-Animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Capsules)
Table 121. South America Non-Animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Capsules)
Table 122. South America Non-Animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Capsules)
Table 123. South America Non-Animal Softgel Capsules Sales Quantity by Country (2018-2023) & (M Capsules)
Table 124. South America Non-Animal Softgel Capsules Sales Quantity by Country (2024-2029) & (M Capsules)
Table 125. South America Non-Animal Softgel Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Non-Animal Softgel Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Capsules)
Table 128. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Capsules)
Table 129. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Capsules)
Table 130. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Capsules)
Table 131. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Region (2018-2023) & (M Capsules)
Table 132. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Region (2024-2029) & (M Capsules)
Table 133. Middle East & Africa Non-Animal Softgel Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Non-Animal Softgel Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Non-Animal Softgel Capsules Raw Material
Table 136. Key Manufacturers of Non-Animal Softgel Capsules Raw Materials
Table 137. Non-Animal Softgel Capsules Typical Distributors
Table 138. Non-Animal Softgel Capsules Typical Customers
List of Figures
Figure 1. Non-Animal Softgel Capsules Picture
Figure 2. Global Non-Animal Softgel Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Animal Softgel Capsules Consumption Value Market Share by Type in 2022
Figure 4. Plant Polysaccharides Softgel Capsules Examples
Figure 5. Starch Softgel Capsules Examples
Figure 6. Global Non-Animal Softgel Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Non-Animal Softgel Capsules Consumption Value Market Share by Application in 2022
Figure 8. Health Supplements Examples
Figure 9. Pharmaceutical Examples
Figure 10. Others Examples
Figure 11. Global Non-Animal Softgel Capsules Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-Animal Softgel Capsules Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Non-Animal Softgel Capsules Sales Quantity (2018-2029) & (M Capsules)
Figure 14. Global Non-Animal Softgel Capsules Average Price (2018-2029) & (US$/Capsule)
Figure 15. Global Non-Animal Softgel Capsules Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Non-Animal Softgel Capsules Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Non-Animal Softgel Capsules by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Non-Animal Softgel Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Non-Animal Softgel Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Non-Animal Softgel Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Non-Animal Softgel Capsules Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Non-Animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Non-Animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Non-Animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Non-Animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Non-Animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Non-Animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Non-Animal Softgel Capsules Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Non-Animal Softgel Capsules Average Price by Type (2018-2029) & (US$/Capsule)
Figure 30. Global Non-Animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Non-Animal Softgel Capsules Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Non-Animal Softgel Capsules Average Price by Application (2018-2029) & (US$/Capsule)
Figure 33. North America Non-Animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Non-Animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Non-Animal Softgel Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Non-Animal Softgel Capsules Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Non-Animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Non-Animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Non-Animal Softgel Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Non-Animal Softgel Capsules Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Non-Animal Softgel Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Non-Animal Softgel Capsules Consumption Value Market Share by Region (2018-2029)
Figure 53. China Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Non-Animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Non-Animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Non-Animal Softgel Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Non-Animal Softgel Capsules Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Non-Animal Softgel Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Non-Animal Softgel Capsules Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Non-Animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Non-Animal Softgel Capsules Market Drivers
Figure 74. Non-Animal Softgel Capsules Market Restraints
Figure 75. Non-Animal Softgel Capsules Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Non-Animal Softgel Capsules in 2022
Figure 78. Manufacturing Process Analysis of Non-Animal Softgel Capsules
Figure 79. Non-Animal Softgel Capsules Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
